Iambic Therapeutics

See today's Reuters piece by Martin Coulter about our launch of "Enchant", a state-of-the art multi-modal AI model that predicts clinical properties of potential medicines from the earliest stages of drug discovery. Nvidia-backed AI firm Iambic unveils drug discovery ‘breakthrough’. https://lnkd.in/gd2Y3Y7j #AI #BioTech #Healthcare #Innovation #Enchant

Introducing Enchant™, our groundbreaking multimodal AI model designed to predict clinical outcomes from the earliest stages of drug discovery. Pushing through the R&D "data wall," Enchant leverages abundant discovery-stage data with small amounts of human data to better predict key clinical properties of drug candidates at the earliest stages of research. See today's white paper and press release describing how our state-of-the-art multi-modal transformer model provides predictive insights into pharmacokinetics and other drug properties to reduce cost and increase the quality of clinical drug candidates. #AI #BioTech #Healthcare #Innovation #Enchant https://lnkd.in/gdd5zsRy https://lnkd.in/gzxhcb4H

We are honored to have our CEO Thomas Miller recognized by Goldman Sachs as one of the most exceptional entrepreneurs of the year at this week’s Builders and Innovators Summit. #GSInnovators #AI #Machinelearning @drugdiscovery

Join Joseph Dennis at the Laboratory Robotics Interest Group - LRIG Bay Area Fall Event for his presentation "Empowering Discovery with an AI-Driven Automated Platform” and a discussion of the critical role of automation in Iambic’s drug discovery platform. #AI, #drugdiscovery, #machinelearning

Italian Tech Week was so fun! It was a real honour to be on the stage with Ileana Pirozzi, Fred (Federico) Parietti and Raviv Pryluk. But also wonderful to be in the City of #Torino and to meet so many people focused on improving the world through the creation of technology. #italiantechweek #biotech #AI for #drugdiscovery

We are deeply honored to be named to this year’s Endpoints 11 list of most promising private biotech companies. This recognition by Endpoints News is a tribute to the entire Iambic Therapeutics team and their tremendous work in bringing highly-differentiated, AI-discovered drug candidates to clinic. Thank you to John Carroll, Andrew Dunn and Drew Armstrong for this award and their appreciation for the transformational advances AI and machine learning bring to the discovery of potential breakthrough medicines for patients. #EndpointsNews #AI #drugdiscovery #machinelearning See today’s announcement here: https://lnkd.in/gMuC8s67

We are pleased to announce a new strategic partnership with CNS therapeutics leader Lundbeck and to use our state-of-the-art, AI-driven drug discovery platform to accelerate research that can unlock novel development candidates for neurological disease.  See today’s announcement here: https://lnkd.in/g59Y9smS #AI #machinelearning #Drugdiscovery #CNS

Looking forward to a fascinating panel discussion #italiantechweek on The bio-industrial revolution: Robots, Quantum and AI, which will be moderated by https://lnkd.in/gSU57pRS of https://lnkd.in/g-CKhg9G. Panelists include our CTO Fred Manby along with PhaseV CEO https://lnkd.in/gXtgGHbx and Multiply Labs CEO https://lnkd.in/g-ArDjrU. The program takes place on September 25th at 15:02 local time on the Fucine Stage at the OGR Torino Exhibition Hall in Turin, Italy. We hope to see you there. #AI #machinelearning #drugdiscovery #ITW24

Our globetrotting CTO Fred Manby lands in Barcelona on September 19th to present and participate in a fireside chat on The future of AI in shaping Drug Discovery at the 24th Drug Discovery Innovation Programme. Dr. Manby will discuss our AI/ML and automated experimentation platform and how it is transforming the pace at which highly-differentiated drug candidates advance from discovery to the clinic. #drugdiscovery #AI #machinelearning

Join Iambic’s CTO Fred Manby at the 1st Quantum Mechanics in Pharma meeting in London next week for a discussion on the role of quantum mechanics in driving the future of drug discovery. This will include a discussion of Iambic’s OrbNet machine learning model that provides the accuracy of quantum chemistry a thousand times faster. #drugdiscovery #quantum #AI #machinelearning